Tolerability of selective cyclooxygenase inhibitor, celecoxib, in patients with analgesic intolerance

被引:28
作者
Çelik, G [1 ]
Pasaoglu, G [1 ]
Bavbek, S [1 ]
Abadoglu, Ö [1 ]
Dursun, B [1 ]
Mungan, D [1 ]
Misirligil, Z [1 ]
机构
[1] Ankara Univ, Sch Med, Cebeci Hosp, Dept Chest Dis,Div Allergy, TR-06100 Ankara, Turkey
关键词
celecoxib; aspirin-induced asthma; hypersensitivity reaction; pseudoallergic reactions; oral provocation tests;
D O I
10.1081/JAS-51326
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Intolerance reactions to acetyl salicylic acid (ASA) and nonsteroidal anti-inflammatory drugs ( NSAIDs) are common and caused by inhibition of COX-1 enzyme. Therefore, drugs that selectively inhibit COX-2 enzyme may be safe in these subjects. In this study, we evaluated the tolerability of celecoxib, a selective COX-2 inhibitor, in patients with analgesic intolerance. The eligible study population consisted of patients with a history of urticaria/angioedema, naso-ocular symptoms, bronchospasm, and/or anaphylactoid reaction induced by ASA and/or NSAIDs. A single-blind, placebo-controlled oral challenge test was performed in the hospital setting. On 2 separate days, 1/4 and 3/4 divided doses of placebo and celecoxib ( Celebrex 200 mg, Pfizer, Turkey) were given with 2-hour intervals. Seventy-five subjects ( mean age: 38.2 +/- 1.4 years; F: M: 55: 20) were included in the study. Twenty-one subjects had asthma. No reaction was observed with placebo or celecoxib provocation. Although celecoxib seems to be a safe alternative drug in our study group, considering its serious adverse events reported in the literature, the drug should be recommended for patients with analgesic intolerance only after being tested by an experienced allergist.
引用
收藏
页码:127 / 131
页数:5
相关论文
共 37 条
  • [1] The selective cyclooxygenase-2 inhibitor celecoxib is a safe alternative in patients with pseudo-allergic reactions to nonsteroidal and-inflammatory drugs
    Ahlbach, S
    Usadel, KH
    Kaufman, R
    Boehncke, WH
    [J]. MEDIZINISCHE KLINIK, 2003, 98 (05) : 242 - 244
  • [2] ANDRI L, 1994, ANN ALLERGY, V72, P29
  • [3] [Anonymous], 1987, AM REV RESPIR DIS, V136, P225
  • [4] The use of nimesulide in patients with acetylsalicylic acid and nonsteroidal anti-inflammatory drug intolerance
    Bavbek, S
    Çelik, G
    Ediger, D
    Mungan, D
    Demirel, YS
    Misirligil, Z
    [J]. JOURNAL OF ASTHMA, 1999, 36 (08) : 657 - 663
  • [5] Safety of selective COX-2 inhibitors in aspirin/nonsteroidal anti-inflammatory drug-intolerant patients:: Comparison of nimesulide, meloxicam, and rofecoxib
    Bavbek, S
    Çelik, G
    Özer, F
    Mungan, D
    Misirligil, Z
    [J]. JOURNAL OF ASTHMA, 2004, 41 (01) : 67 - 75
  • [6] Rofecoxib safe in NSAID hypersensitivity
    Berges-Gimeno, MP
    Camacho-Garrido, E
    García-Rodriguez, RM
    Alfaya, T
    García, CM
    Hinojosa, M
    [J]. ALLERGY, 2001, 56 (10) : 1017 - 1018
  • [7] The atopy trait in hypersensitivity to nonsteroidal anti-inflammatory drugs
    Bochenek, G
    Nizankowska, E
    Szczeklik, A
    [J]. ALLERGY, 1996, 51 (01) : 16 - 23
  • [8] BOEHNCKE WH, 2003, ALLERGY S, V58, P1226
  • [9] The prevalence of allergic diseases and atopy in Ankara, Turkey:: A two-step population-based epidemiological study
    Çelik, G
    Mungan, D
    Bavbek, S
    Sin, B
    Ediger, D
    Demirel, Y
    Misirligil, Z
    [J]. JOURNAL OF ASTHMA, 1999, 36 (03) : 281 - 290
  • [10] Clinical features and atopy profile in Turkish subjects with analgesic intolerance
    Çelik, G
    Mungan, DA
    Özer, F
    Ediger, D
    Bavbek, S
    Sin, B
    Demirel, YS
    Misirligil, Z
    [J]. JOURNAL OF ASTHMA, 2002, 39 (02) : 101 - 106